Can intermittent fasting help paralyzed veterans lose weight?
NCT ID NCT05921487
First seen Jun 27, 2026 · Last updated Sep 03, 2026 · Updated 4 times
Summary
This study looks at whether time-restricted eating (a form of intermittent fasting) is a practical way for veterans with spinal cord injury and obesity to lose weight. Fifteen veterans with paraplegia will try eating all their daily calories within a set window of time for 6 weeks. The goal is to see if they can stick with the plan and gather information for a larger future study.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
15 people
The number who actually took part.
- Started
-
Sep 2023
- Expected to finish
-
Aug 2027
An estimate. End dates often move.
- Lead sponsor
-
A government agency
The lead sponsor is a US federal agency other than the NIH.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 89 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Veteran * A member of the Spinal Cord Injury/Disorder (SCI/D) registry through the Syracuse VA, including both hub and spoke sites * A qualifying diagnosis of SCI within the SCI/D registry * Neurologic level of injury from T1 to S5, based on most recent Status Update or American Spinal Injury Association Impairment Scale (ASIA) examination, or a diagnosis of a hereditary form of paraplegia (such as familial spastic paraplegia or hereditary spastic paraplegia) * ASIA Impairment Scale grade A-D * Chronic SCI (\> 1 year from date of SCI or diagnosis of SCI) * BMI \> 22 - the BMI used to diagnose obesity in individuals with SCI * Mean eating window of at least 10 hours per day Exclusion Criteria: * Females who are pregnant (tested via urinary human chorionic gonadotropin (hCG)), planning to become pregnant in the next 6 months, or breast-feeding * A member of the SCI/D registry through the Syracuse VA, with a qualifying diagnosis of MS or ALS * Diagnosis of heart failure * Diagnosis of diabetes mellitus, type 1 * Diagnosis of diabetes mellitus, type 2, and on insulin or other antidiabetic agent with high incidence of hypoglycemia o Of note, antidiabetic agents with low incidence of hypoglycemia are: metformin, Glucagon-like peptide-1 (GLP-1) receptor agonists, Sodium-glucose cotransporter-2 (SGLT2) inhibitors, Dipeptidyl peptidase 4 (DPP-4) inhibitors, alpha glucosidase inhibitors, thiazolidinediones (as discussed with VA pharmacist) * Diagnosis of End Stage Renal Disease * Diagnosis of dementia * Diagnosis of orthostatic hypotension and prescribed midodrine or fludrocortisone * History of syncopal episode in the month prior to the study * History of significant weight loss (\> 10% body weight) in the month prior to the study * History of eating disorders (e.g., anorexia or bulimia) within the last five years, or clearance from a mental health provider * History of active suicidal ideation in the last six months, or clearance from a mental health provider * Currently prescribed weight loss medication (e.g., liraglutide) * Currently prescribed corticosteroids * Current acute medical issues including cancer, sepsis, advanced liver failure, porphyria, or uncontrolled hyperthyroidism
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Obesity are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Syracuse VA Medical Center, Syracuse, NY
Syracuse, New York, 13210-2716, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Custom knee guides put to the test in obese patients
- A pill for obesity? early human trial puts MDR-001 to the test
- Can a weekly shot help people who still struggle with weight after bariatric surgery?
- Do GLP-1 Weight-Loss drugs change how teens eat and feel?
- Can a Self-Balancing exoskeleton make daily tasks more satisfying than a wheelchair?
- Can electrical muscle stimulation boost exercise benefits after menopause?